AR116878A1 - Vacuna de ibv h52 con proteína espicular heteróloga - Google Patents

Vacuna de ibv h52 con proteína espicular heteróloga

Info

Publication number
AR116878A1
AR116878A1 ARP190103116A ARP190103116A AR116878A1 AR 116878 A1 AR116878 A1 AR 116878A1 AR P190103116 A ARP190103116 A AR P190103116A AR P190103116 A ARP190103116 A AR P190103116A AR 116878 A1 AR116878 A1 AR 116878A1
Authority
AR
Argentina
Prior art keywords
ibv
spicular
protein
subject
heterological
Prior art date
Application number
ARP190103116A
Other languages
English (en)
Inventor
Hans Philipp
- Mundt Egbert Siegfried Christian
Annika Kraemer-Kuehl
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of AR116878A1 publication Critical patent/AR116878A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un IBV (virus de la bronquitis infecciosa) H52 que codifica una proteína S (espicular) heteróloga o fragmento de esta. Además, una composición inmunógena que comprende dicho IBV H52 que codifica una proteína S (espicular) heteróloga o fragmento de esta. Asimismo, métodos para inmunizar un sujeto, que comprenden administrar a dicho sujeto la composición inmunógena de la presente. Además, métodos para tratar o prevenir signos clínicos causados por un IBV en un sujeto que lo necesita, en donde el método comprende administrar al sujeto una cantidad terapéuticamente eficaz de una composición inmunógena de acuerdo con la presente.
ARP190103116A 2018-10-31 2019-10-28 Vacuna de ibv h52 con proteína espicular heteróloga AR116878A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18203637 2018-10-31

Publications (1)

Publication Number Publication Date
AR116878A1 true AR116878A1 (es) 2021-06-23

Family

ID=64048883

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190103116A AR116878A1 (es) 2018-10-31 2019-10-28 Vacuna de ibv h52 con proteína espicular heteróloga

Country Status (12)

Country Link
US (1) US11696947B2 (es)
EP (1) EP3873515A1 (es)
JP (2) JP7350864B2 (es)
KR (1) KR20210084596A (es)
CN (1) CN112996536A (es)
AR (1) AR116878A1 (es)
BR (1) BR112021008390A2 (es)
CO (1) CO2021005069A2 (es)
EA (1) EA202191147A1 (es)
IL (1) IL282467B1 (es)
MX (1) MX2021004859A (es)
WO (1) WO2020089166A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11512115B2 (en) 2019-05-10 2022-11-29 Boehringer Ingelheim Vetmedica Gmbh Modified S1 subunit of the coronavirus spike protein
AU2021378483A1 (en) * 2020-11-12 2023-06-08 Intervet International B.V. Recombinant vectors encoding chimeric coronavirus spike proteins and use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
ATE463253T1 (de) 2000-02-29 2010-04-15 Wyeth Llc In ovo schutz gegen infektiöse bronchitis
WO2004078203A2 (en) 2003-03-03 2004-09-16 Akzo Nobel N.V. Infectious bronchitis virus with an altered spike gene
ZA200603404B (en) * 2003-10-30 2007-09-26 Boehringer Ingelheim Vetmed Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
CA2619174C (en) * 2005-08-15 2016-12-20 Vaxin, Inc. Immunization of avians by administration of non-replicating vectored vaccines
GB0911794D0 (en) * 2009-07-07 2009-08-19 Animal Health Inst Chimaeric protein
CN103642759B (zh) 2013-11-15 2016-01-27 中国农业科学院兰州兽医研究所 嵌合ibv 4/91株纤突蛋白膜外区基因片段的重组传染性支气管炎病毒及其构建方法和应用
CN104694488A (zh) 2013-12-10 2015-06-10 江苏省家禽科学研究所 鸡传染性支气管炎病毒致弱株rH120-YZ及其构建方法
GB201413020D0 (en) * 2014-07-23 2014-09-03 Pribright The Inst Coronavirus
US9764025B2 (en) * 2014-10-20 2017-09-19 Auburn University Adaptation of attenuated infectious bronchitis virus (IBV) to embryonic kidney cells and vaccine thereby produced
EA201791907A1 (ru) * 2015-02-26 2018-02-28 Бёрингер Ингельхайм Ветмедика Гмбх Бивалентная вакцина против вируса свиного гриппа
JP6874023B2 (ja) * 2016-06-16 2021-05-19 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハーＢｏｅｈｒｉｎｇｅｒ Ｉｎｇｅｌｈｅｉｍ Ｖｅｔｍｅｄｉｃａ ＧｍｂＨ 伝染性気管支炎ウイルスに対するワクチン

Also Published As

Publication number Publication date
JP2023116544A (ja) 2023-08-22
WO2020089166A1 (en) 2020-05-07
IL282467B1 (en) 2024-08-01
EP3873515A1 (en) 2021-09-08
BR112021008390A2 (pt) 2021-09-28
EA202191147A1 (ru) 2021-08-23
CN112996536A (zh) 2021-06-18
IL282467A (en) 2021-06-30
KR20210084596A (ko) 2021-07-07
US20200129614A1 (en) 2020-04-30
CO2021005069A2 (es) 2021-04-30
JP7350864B2 (ja) 2023-09-26
US11696947B2 (en) 2023-07-11
JP2022502513A (ja) 2022-01-11
MX2021004859A (es) 2021-06-15

Similar Documents

Publication Publication Date Title
CO2021005066A2 (es) Vacuna de ibv 4/91 con proteína espicular heteróloga
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
BR112016001192A2 (pt) Vacina contra a raiva
MX2018015506A (es) Vacuna contra virus de bronquitis infecciosa.
CO2021005069A2 (es) Vacuna de ibv h52 con proteína espicular heteróloga
PE20121685A1 (es) Antigeno ndv recombinante y usos del mismo
CL2019003393A1 (es) Virus oncolíticos y método.
AR109538A1 (es) Vacuna contra la gripe porcina
WO2017214596A8 (en) Compositions and methods for preventing and treating zika virus infection
CO2018001010A2 (es) Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por vrsh
EA201391200A1 (ru) Способы и композиции для вакцинации от staphylococcus aureus
PH12021550441A1 (en) Modified pedv spike protein
CL2021002727A1 (es) Vacuna con subunidades del vfpc
UY39464A (es) Composiciones y métodos para la prevención y/o tratamiento de la covid-19
PE20211295A1 (es) Anticuerpos anti il-36 y procedimientos de uso de estos
CO2021016301A2 (es) Arn terapéutico para cáncer de ovario
BR132018069012E2 (pt) uso de anticorpos policlonais humanos ou fragmentos destes, e, composição farmacêutica
CO2018000255A2 (es) Polipéptido quimérico, vacuna contra la babesiosis, métodos de detección y kit
MX2022006414A (es) Vacuna triple contra avibacterium paragallinarum y el virus de la encefalomielitis aviar y el virus de la viruela aviar.
BR112022010361A2 (pt) Anticorpos biespecíficos com cisteínas de intercadeias combinadas alternativamente e usos dos mesmos
MX2020008062A (es) Constructos de ácido nucleico de anticuerpos para usar contra el virus sincicial respiratorio.
AR109291A1 (es) Clon de adnc del virus del síndrome reproductivo y respiratorio porcino y usos del mismo
AR127807A1 (es) Vacuna contra el coronavirus
EA202091829A1 (ru) Конструкты антител на основе нуклеиновой кислоты для использования против респираторного синцитиального вируса
AR122208A1 (es) Anticuerpos neutralizantes contra coronavirus asociado a sars